I believe still on Chapter 11 but were selling some of the assets to pay debtors which it may had resembled like a 7... https://www.bloomberg.com/press-releases/2019-11-25/alexion-pharmaceuticals-ico-s-new-partner-for-the-development-and-commercialization-of-ico-008 although I am not sure if this was fully done since last year this was one of IMNP's news: https://www.immunepharma.com/news They got some funds with the sale of Ceplene and understand the company has very little debt now. IMNP still holds a sizeable interest in Cytovia which has an excellent prospect to develop the NK Cells Cancer treatment among other things.